EU drug regulator approves Novartis' meningitis B vaccine
Excerpt:There are five types of bacterial meningitis. While vaccines exist to protect against the other four, none has previously been licensed for type B meningitis. In Europe, type B is the most common, causing 3,000 to 5,000 cases every year. Meningitis mainly affects infants and children. It kills about 8 percent of patients and leaves others with lifelong consequences such as brain damage. In a statement on Friday, Andrin Oswald of Novartis said he is "proud of the major advance" the company has made in developing its vaccine Bexsero. It is aimed at children over two months of age, and Novartis is hoping countries will include the shot among the routine ones for childhood diseases such as measles. Novartis said the immunization has had side effects such as fever and redness at the injection site. Recommendations from the European Medicines Agency are usually adopted by the European Commission.
People:
Novartis
Overall Sentiment: 0.136873
Relevance: 0.886117
| Sentiment | Quote |
|---|---|
| 0.108374 | Novartis said he is "proud of the major advance" ... |
| Sentiment Stats: |
|
Andrin Oswald
Overall Sentiment: 0.276001
Relevance: 0.37441
Key:
- Aggregate Sentiment is meant to be an indicator of an individual's overall sentiment.
- The Mean is meant to be an indicator of an individual's average comment sentiment.
- The Standard Deviation, when there are enough quotes, will indicate an individual's consistency of sentiment (i.e. a Standard Deviation of 0 would mean they were very consistent in their sentiment and 1 would mean they were very inconsistent).
Note that quote stats are likely to be meaningless beyond the aggregate score due to the tiny sample size. However, they are always provided just in case you find something useful there.
Additional Info:
Continent: Europe
Overall Sentiment: 0
Relevance: 0.319396
Disambiguation: References:
HealthCondition: Meningitis
Overall Sentiment: 0.0523502
Relevance: 0.826069
Disambiguation: DiseaseOrMedicalCondition | DiseaseReferences:
HealthCondition: bacterial meningitis
Overall Sentiment: 0
Relevance: 0.685383
Organization: European Medicines Agency
Overall Sentiment: 0.0464748
Relevance: 0.438033
Organization: European Commission
Overall Sentiment: 0.0566245
Relevance: 0.361028
URL Meta
Webpage Provided Desc:
Site Provided Title:
URL Provided Keywords:
Source : EU drug regulator approves Novartis' meningitis B vaccine
Europe's top drug regulator has recommended approval for the first vaccine against meningitis B, made by Novartis AG
Site Provided Title:
EU drug regulator approves Novartis' meningitis B vaccine
URL Provided Keywords:
- bacterial meningitis
- childhood diseases
- common
- meningitis
- novartis
- side effects
- U S
- vaccines
Source : EU drug regulator approves Novartis' meningitis B vaccine

No comments:
Post a Comment